MATTESINI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 3.439
EU - Europa 1.746
AS - Asia 1.535
SA - Sud America 592
AF - Africa 56
OC - Oceania 32
Totale 7.400
Nazione #
US - Stati Uniti d'America 3.392
RU - Federazione Russa 805
BR - Brasile 454
SG - Singapore 393
IT - Italia 375
CN - Cina 320
VN - Vietnam 290
HK - Hong Kong 229
IE - Irlanda 150
SE - Svezia 131
KR - Corea 109
AR - Argentina 64
FR - Francia 58
PL - Polonia 56
IN - India 52
DE - Germania 51
FI - Finlandia 40
AU - Australia 31
ID - Indonesia 26
EC - Ecuador 25
ES - Italia 24
CA - Canada 20
BD - Bangladesh 19
CI - Costa d'Avorio 19
GB - Regno Unito 19
JO - Giordania 15
UA - Ucraina 15
ZA - Sudafrica 14
PY - Paraguay 13
IQ - Iraq 12
PK - Pakistan 12
MX - Messico 11
JP - Giappone 10
VE - Venezuela 10
CO - Colombia 7
IR - Iran 7
PE - Perù 7
CL - Cile 6
EG - Egitto 6
JM - Giamaica 6
KE - Kenya 6
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
AZ - Azerbaigian 4
NL - Olanda 4
TR - Turchia 4
TW - Taiwan 4
BO - Bolivia 3
PH - Filippine 3
SA - Arabia Saudita 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AT - Austria 2
CR - Costa Rica 2
DK - Danimarca 2
GT - Guatemala 2
MY - Malesia 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.400
Città #
Santa Clara 892
Ashburn 397
Fairfield 308
Singapore 288
Hong Kong 193
Seattle 147
Dublin 136
Woodbridge 133
Houston 127
Cambridge 112
Seoul 109
Milan 102
Ho Chi Minh City 96
Wilmington 90
San Jose 89
Beijing 82
Buffalo 65
Hanoi 64
Medford 57
Warsaw 55
Moscow 54
Lawrence 53
Rome 48
Los Angeles 46
Princeton 45
The Dalles 45
Lauterbourg 42
São Paulo 34
Chandler 33
Clifton 33
Hefei 33
Mumbai 33
Helsinki 29
Ann Arbor 24
Florence 24
Melbourne 23
New York 22
Altamura 20
Abidjan 19
Munich 19
Barcelona 18
Shanghai 18
Bologna 17
Dallas 16
Dong Ket 16
Redondo Beach 16
Council Bluffs 15
Franklin 14
Haiphong 14
Kent 14
San Diego 14
Guangzhou 13
Brasília 12
Norwalk 11
Falls Church 10
Turin 10
Da Nang 9
Miano 9
Baghdad 8
Chicago 8
Frankfurt am Main 8
Hillsboro 8
Jakarta 8
Montreal 8
Naples 8
Adelaide 7
Biên Hòa 7
Buenos Aires 7
Rio de Janeiro 7
Thái Bình 7
Tokyo 7
Campinas 6
Denver 6
Guayaquil 6
Hải Dương 6
Nairobi 6
Nuremberg 6
Orem 6
Quito 6
Shenzhen 6
Tehran 6
Andover 5
Asunción 5
Bari 5
Curitiba 5
Goiânia 5
Guarulhos 5
Ha Long 5
Johannesburg 5
London 5
Manaus 5
Paris 5
Phoenix 5
Porto Alegre 5
Redmond 5
Salvador 5
Santo André 5
Turku 5
Uberlândia 5
Venice 5
Totale 4.720
Nome #
Quality control in treating patients with patent foramen ovale: 7-year-experience of the Heart and Brain team of the Careggi University Hospital 239
The DESolve novolimus bioresorbable Scaffold: From bench to bedside 213
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: A European perspective 208
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patients 196
Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study 188
A Brief History of Coronary Artery Stents 185
Absorb vs. DESolve: An optical coherence tomography comparison of acute mechanical performances 185
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 180
Percutaneous Trans-septal Mitral Valve-in-Ring Implantation Using a Transcatheter Balloon-Expandable Transcatheter Heart Valve With Elective Intra-Procedural Artero-Venous ECMO in a Patient With Severely Reduced Left Ventricular Ejection Fraction 180
Calcium: A predictor of interventional treatment failure across all fields of cardiovascular medicine 179
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents A Propensity-Matched Comparison of the GHOST-EU and XIENCE v USA Registries 178
Patent foramen ovale closure: how to choose the right device for the right patient 178
A simple step-by-step approach for proficient utilization of the EchoNavigator technology for left atrial appendage occlusion 178
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 174
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: Insights from the GHOST-EU registry 172
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry 165
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry 164
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 163
Bioabsorbable vascular scaffold overexpansion: Insights from in vitro post-expansion experiments 161
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 160
Percutaneous Watchman FLX implantation in a patient with previous mitral valve surgery and large-sized left atrial appendage 160
Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events? 159
ABSORB biodegradable stents versus second-generation metal stents: A comparison study of 100 complex lesions treated under OCT guidance 157
Impact of stent strut design in metallic stents and biodegradable scaffolds 156
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 154
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 154
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry 147
Will Optical Coherence Tomography Become the Standard Imaging Tool for Percutaneous Coronary Intervention Guidance? 146
Il trattamento delle occlusioni coronariche croniche: Stato dell'arte 146
An amber signal lights up before the red: Do not dismiss it 144
TAVR in patients with hip fracture and severe aortic stenosis: how and when? 144
Urgent coronary angiography in out-of-hospital cardiac arrest: a retrospective single centre investigation 140
Very high-pressure dilatation for undilatable coronary lesions: Indications and results with a new dedicated balloon 138
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting 137
Indications and immediate and long-term results of a novel pericardium covered stent graft: Consecutive 5 year single center experience 136
Riserva frazionale di flusso: una breve guida pratica all'utilizzo per l'interventista e il punto di vista del cardiologo clinico 136
[Tips and tricks for using extracorporeal life support devices in the intensive cardiac care unit] 136
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 132
Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents 127
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: Early and midterm outcomes from the European multicentre GHOST-EU registry 125
Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds 119
EuroCTO Club 2018 meeting: "Experts Live" in Toulouse 116
The Forgotten Art of Balloon Angioplasty 114
Bioresorbable Scaffold Thrombosis: Why BRS Size Matters 113
Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation 112
Inducing persistent flow disturbances accelerates atherogenesis and promotes thin cap fibroatheroma development in D374Y-PCSK9 hypercholesterolemic minipigs 111
No-Reflow Complicating Chronic Total Occlusion Coronary Revascularization 93
Stop adding metal layers: Will bioabsorbable scaffolds become the gold standard for late in-stent restenosis and neo-atherosclerosis? 88
Lower interventricular septal thickness from computed tomography predicts the need for pacemaker implantation after TAVR 59
Ischaemic Stroke in Patients with Known Atrial Fibrillation: A Snapshot from a Large University Hospital Experience 15
Totale 7.460
Categoria #
all - tutte 21.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.360


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022325 5 14 19 25 11 17 9 25 15 9 57 119
2022/2023491 77 110 40 16 2 89 73 21 41 2 16 4
2023/2024239 11 29 51 21 16 16 7 37 8 15 19 9
2024/20252.294 100 270 138 336 680 426 17 94 60 48 52 73
2025/20262.834 240 442 260 477 287 94 240 141 170 114 75 294
2026/2027144 144 0 0 0 0 0 0 0 0 0 0 0
Totale 7.460